The Effects of Different Treatment Methods on Blood Hematological Parameters İn COVID 19: A Retrospective Look at Patients in Pandemic İntensive Care Unit During The First Wave of the Pandemic
Yesim Cokay ABUT, Kubra Bolat Gursoy, Fusun ADAM, Didem SARI, Ece KISA
Introduction: In this study, we compared the pre- and post-treatment values of basic hematological
parameters in severe COVID 19 patients, whose were received favipiravir, tocilizumab,
methylprednisolone and convalescent plasma therapy.
Methods: Hematological parameters such as eosinophyl, neutrophil, lymphocyte, platelet count
and, neutrophil / lymphocyte, platelet/ lymphocyte ratio were investigated pre and post treatment of
favipiravir, tocilizumab convalescent plasma and methylprednisolone in severe COVID 19 patients in
ICU.
Results: Lymphocyt values were increased after convelescent plasma theraphy and i.v. methyl prednisolon
group. Eosinophil count improvement was only in the favipiravir group . We found that favipiravir,
convalescent plasma andmethyl prednisolon treatment, were statistically significant increased both NLR
and PLR.
Conclusion : Hematologic parameters and their contribution of the respond of the treatment and clinical
improvement should be taken into account.
